Cite

HARVARD Citation

    Gabrail, N. et al. (n.d.). 330 First-in-man study of gemcitabine hydrochloride oral formulation (D07001-F4) in patients with malignant tumors. European journal of cancer. pp. S64-. [Online]. 
  
Back to record